Quinoline derivatives

Details for Australian Patent Application No. 2003219023 (hide)

Owner Novartis AG

Inventors Gull, Peter; Pombo Villar, Esteban

Agent Davies Collison Cave

Pub. Number AU-B-2003219023

PCT Number PCT/EP03/02321

PCT Pub. Number WO2003/074511

Priority 02005115.7 07.03.02 EP; 02005117.3 07.03.02 EP

Filing date 6 March 2003

Wipo publication date 16 September 2003

Acceptance publication date 30 November 2006

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 02005115.7 07.03.02 EP; 02005117.3 07.03.02 EP

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219023

30 November 2006 Application Accepted

  Published as AU-B-2003219023

29 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219024-IMPLANTABLE DEVICE

2003219022-A METHOD OF PROTECTING THE INTEGRITY OF A COMPUTER PROGRAM